Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1

Status

Completed 2

Sponsor Class

OTHER 8NIH 7INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other neoplasm 1Breast 1

Conditions

Secondary Malignant Neoplasm of Bone 1Breast Neoplasms 1

Interventions

pembrolizumab 1023Carboplatin 964Paclitaxel 933Gemcitabine 794Cisplatin 751Docetaxel 683Bevacizumab 609Pemetrexed 502Nivolumab 487Cyclophosphamide 471Capecitabine 461Fluorouracil 418Dexamethasone 403Rituximab 372Oxaliplatin 348Injections 345atezolizumab 298Trastuzumab 298Leucovorin 288Cetuximab 282Irinotecan 268130-nm albumin-bound paclitaxel 254Prednisone 245Doxorubicin 240Ipilimumab 226Lenalidomide 220fludarabine 218Fulvestrant 217durvalumab 205Erlotinib Hydrochloride 188

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
INDUSTRY × Interventional × High-Intensity Focused Ultrasound Ablation × Clear all
NCT00008437 2012-07-02

MRI-Guided Ultrasound Energy in Treating Patients With Stage I, Stage II, or Stage IIIA Breast Cancer

InSightec

Phase 2 Completed
Breast

Breast Neoplasms

NCT01117246 2012-02-20

Pilot Study for Palliation of Pain in Bone Metastases by MR-HIFU

Philips Healthcare

Phase 1/2 Completed
2 enrolled
Other neoplasm

Secondary Malignant Neoplasm of Bone

Data powered by HemOnc (CC BY 4.0) Colophon âš¡